Osteoporosis medication use over time in the United States and Canada
Hayes KN, Zullo AR, Berry SD, Oganisian A, Aggarwal S, Adegboye M, Cadarette SM. Osteoporos Int. 2025; Apr 2. [Epub ahead of print].
Publications
On-time denosumab dosing recovered rapidly during the COVID-19 pandemic, yet remains suboptimal
Rzepka AM, Cheung AM, Kim S, Gomes T, Cadarette SM. JBMR Plus. 2024; 8(5):ziae027. Epub 2024 April 9, 2024.
Comparison of fracture identification using different definitions in healthcare administrative (claims) data
Konstantelos N, Burden AM, Cheung AM, Kim S, Grootendorst P, Cadarette SM. Pharmacy. 2023; 11(2):53. Epub 2023 Mar 14.
The Ontario Pharmacy Evidence Network Atlas of Smoking Cessation Services
Rzepka AM, Wong L, Chaudhry M, Sproule BA, He N, Cadarette SM. Can Pharm J (Ott). 2022; 155(4):194-9. Epub 2022 Jun 20.
Comparative fracture risk during osteoporosis drug holidays after long-term risedronate versus alendronate therapy: a propensity score-matched cohort study
Hayes KN, Brown KA, Cheung AM, Kim SA, Juurlink DN, Cadarette SM. Ann Intern Med. 2022; 175(3):335-43. Epub 2022 Jan 11.
The Ontario Pharmacy Evidence Network Atlas of Community Pharmacy Influenza Immunizations
Chaudhry M, He N, Waite NM, Houle SKD, Kwong JC, Cadarette SM. Can Pharm J (Ott). 2021; 154(5):305-11. Epub 2021 Aug 11.
The Ontario Pharmacy Evidence Network Interactive Atlas of Professional Pharmacist Services
Cadarette SM, He N, Chaudhry M, Dolovich L. Can Pharm J (Ott). 2021; 154(3):153-9. Epub 2021 May 28.
Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use
Hayes KN, He N, Brown KA, Cheung AM, Juurlink DN, Cadarette SM. Osteoporos Int. 2021; 32(7):1413-20. Epub 2021 Jan 7.
Impact of the 2016 policy change on the delivery of Medscheck services in Ontario: an interrupted time-series analysis
Shakeri A, Dolovich L, MacCallum L, Gamble JM, Zhou L, Cadarette SM. Pharmacy. 2019; 7(3):E115. Epub 2019 Aug 12.
Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes
Hayes KN, Ban JK, Athanasiadis G, Burden AM, Cadarette SM. Osteoporos Int. 2019; 30(11):2311-9. Epub 2019 Jul 17.